Shared on08 Aug 25
American Well’s valuation has weakened as its Future P/E increased and Net Profit Margin declined, justifying a stagnant analyst price target at $9.50. What's in the News Amwell, as part of a Leidos-led partnership, was awarded an extension of its Digital First contract to support the Military Health System (MHS), serving about 9.6 million beneficiaries.
Shared on24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 5.57%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 13%
AnalystConsensusTarget has increased revenue growth from 4.5% to 6.0%.